A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Pierre Quartier Angelo Ravelli Abhijit Chakraborty Brigitte Bader-Meunier Nico M Wulffraat Alberto Martini |
| Publication date | February 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |